María del Pilar de la Huerta Martínez

Noscira SA develops and manufactures pharmaceutical products. It focuses on developing drugs for the treatment of nervous system disorders, especially the Alzheimer's disease. The company was founded in 2000 and is headquartered in Tres Cantos, Spain

Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology. It operates through the Biopharmaceuticals and Consumer Chemicals segments. The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products. The company was founded on August 3, 1939 and is headquartered in Madrid, Spain.

Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005.

Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain.

Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain.